1.
Dig Dis Sci
; 68(5): 2158-2160, 2023 05.
Article
in English
| MEDLINE | ID: covidwho-2280093
2.
Clin Gastroenterol Hepatol
; 20(7): 1606-1608.e2, 2022 07.
Article
in English
| MEDLINE | ID: covidwho-1670284
ABSTRACT
Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD).1 Patients with IBD historically have had low vaccine uptake relative to the general population.2 However, a recent survey suggested a rate higher than that of the general population with regard to COVID-19 vaccine intent among the IBD population. Their study was limited being that 96% of the patients surveyed identified as White, and 88% had attained a bachelor's degree or higher level of education.3 Therefore, these findings may not be representative of the IBD population as a whole. Previous studies have indeed identified disparities in influenza vaccine uptake within the IBD population.4,5.
Subject(s)
COVID-19 , Inflammatory Bowel Diseases , Influenza Vaccines , COVID-19/prevention & control , COVID-19 Vaccines , Humans , Surveys and Questionnaires
3.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
; 2021.
Article
in English
| EuropePMC | ID: covidwho-1564781